Profile Fecal Analysis of Neutropenic Enterocolitis — PROFANE

Neutropenic Enterocolitis Clinical Trial

Official title:
Neutropenic Enterocolitis in Critically Ill Hematological Patients: Taxonomic and Functional Analysis of Gut Microbiota

Status Recruiting

Clinical Trial Summary

A prospective, single-center, cohort study to allow collecting observations of patients receiving induction chemotherapy for primary Acute Myeloid Leukemia (AML), collecting biological samples(including fecal samples for microbiota analyses, and metagenomic profiling in blood samples) and clinical outcomes (notably the occurrence of neutropenic enterocolitis), with a nested case-control analysis comparing patients with or without neutropenic enterocolitis

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04438278
Study type	Observational
Source	Assistance Publique - Hôpitaux de Paris
Contact	Lara Zafrani, MD PhD
Phone	+33 1 42 49 49 49
Email	lara.zafrani@aphp.fr
Status	Recruiting
Phase
Start date	July 8, 2020
Completion date	July 2023

View Details

See also
Status	Clinical Trial	Phase
Enrolling by invitation	`NCT02145923` - Effectiveness and Safety of MMSCs for Enhancing Hematopoietic Recovery and Prophylaxis of Neutropenic Enterocolitis	Phase 1/Phase 2
Completed	`NCT04813679` - Bed-side Ultrasound in Neutropenic Enterocolitis
Recruiting	`NCT01699516` - Non-invasive Contrast Enhanced Ultrasound Sonography in Intestinal Acute Graft-vs-Host Disease	N/A